当前位置: 首页 > 期刊 > 《中国现代医生》 > 2017年第15期
编号:13050538
Raf—1、MEK—2、ERK—1在胃癌组织中的表达及其意义(4)
http://www.100md.com 2017年5月25日 《中国现代医生》 2017年第15期
     [8]劉爱华,姜勇.丝裂原活化蛋白激酶与肿瘤[J].中华医学杂志,2001,81(12):761-763.

    [9]丁桂霞,张爱华, 陈荣华.Ras/Raf/ERK 信号传导通路在肾脏疾病中作用的研究进展[J].国外医学(儿科学分册),2000,27(5):231-235.

    [10]Ramnath N,Adjei A.Inhibitors of Raf kinase and MEK signaling[J].Update On Cancer Therapeutics,2007,2:111-118.

    [11]Wang D,Boerner SA,Winkler JD,et al.Clinical experience of MEK inhibitors in cancer therapy[J]. Biochimicaet Biophysica Acta,2007,1773:1248-1255.

    [12]Tan X,Tamori Y,Egami H,et al.Analysis of invasion-metastasis mechanism in pancreatic cancer:involvement of tight junctiontransmembrane protein occludin and MEK/ERK signal transduction pathway in cancer cell dissociation[J].Oncol Rep,2004,11(5):993-998.

    [13]Viala E,Pouyssegur J.Regulation of tumor cell motility by ERK mitogen-activated protein kinases[J].Ann NY Acad Sci,2004,1030:208-218.

    [14]Meng F,Dong B,Li H,et al.RNAi-mediated inhibition of Raf-1 leads to decreased angiogenesis and tumor growth in gastric cancer[J].Cancer Biol Ther,2009,8(2):174-179.

    [15]James AM,Linda SS,William HC,et al.Roles of the Raf/MEK/ERK pathway in cell growth,malignant transformation and drug resisitance[J].Biochimicaet Biop hysica Acta,2007,1771:1263-1284.

    [16]Steelman LS,Franklin RA,Abrams SL,et al.Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy[J].Leu-kemia,2011,25(7):1080-1094., 百拇医药(姜浩 孙治国)
上一页1 2 3 4